Boston Scientific Corp.‘s Farapoint, its latest pulsed field ablation (PFA) catheter, received U.S. FDA approval for use as an adjunctive device when treating persistent atrial fibrillation that requires cavotricuspid isthmus ablation, CEO Mike Mahoney reported at the J.P. Morgan Healthcare...